Androgen signalling and steroid receptor crosstalk in endocrine cancers

Endocrine-Related Cancer

Volumn 21, Issue 4, 2014, Pages

  Claessens, Frank ^a   Tilley, Wayne ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; STEROID RECEPTOR; ANDROGEN RECEPTOR; ESTROGEN RECEPTOR;

BREAST CANCER; EDITORIAL; ENDOCRINE TUMOR; ENDOMETRIUM CANCER; HUMAN; OVARY CANCER; PROSTATE CANCER; SIGNAL TRANSDUCTION; ANIMAL; BREAST TUMOR; FEMALE; MALE; METABOLISM; PROSTATE TUMOR;

ANDROGENS; ANIMALS; BREAST NEOPLASMS; ESTROGENS; FEMALE; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 84905983824     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-14-0274     Document Type: Editorial

References (14)

1. Allan CA, Collins VR, Frydenberg M, McLachlan RI & Matthiesson KL 2014 Androgen deprivation therapy complications. Endocrine-Related Cancer 21 T119-T129. (doi:10.1530/ERC-13-0467)
2. Barfeld SJ, Itkonen HM, Urbanucci A & Mills IG 2014 Androgen-regulated metabolism and biosynthesis in prostate cancer. Endocrine-Related Cancer 21 T57-T66. (doi:10.1530/ERC-13-0515)
3. Gibson DA, Simitsidellis I, Collins F & Saunders PT 2014 Evidence of androgen action in endometrial and ovarian cancers. Endocrine-Related Cancer 21 T203-T218. (doi:10.1530/ERC-13-0551)
4. Gonugunta VK, Miao L, Sareddy GR, Ravindranathan P, Vadlamudi R & Raj GV 2014 The social network of PELP1 and its implications in breast and prostate cancers. Endocrine-Related Cancer 21 T79-T86. (doi:10.1530/ERC-13-0502)
5. Helsen C, Van den Broeck T, Voet A, Prekovic S, Van Poppel H, Joniau S & Claessens F 2014 Androgen receptor antagonists for prostate cancer therapy. Endocrine-Related Cancer 21 T105-T118. (doi:10.1530/ERC-13-0545)
6. Koryakina Y, Ta HQ & Gioeli D 2014 Androgen receptor phosphorylation: biological context and functional consequences. Endocrine-Related Cancer 21 T131-T145. (doi:10.1530/ERC-13-0472)
7. McNamara K, Moore N, Hickey T, Sasano H & Tilley W 2014 Complexities of androgen receptor signalling in breast cancer. Endocrine-Related Cancer 21 T161-T181. (doi:10.1530/ERC-14-0243)
8. Nelson AW, Tilley WD, Neal DE & Carroll JS 2014 Oestrogen receptor β in prostate cancer: friend or foe? Endocrine-Related Cancer 21 T219-T234. (doi:10.1530/ERC-13-0508)
9. Nieto CM, Rider LC & Cramer SD 2014 Influence of stromal-epithelial interactions on androgen action. Endocrine-Related Cancer 21 T147-T159. (doi:10.1530/ERC-14-0138)
10. Penning TM 2014 Androgen biosynthesis in castration resistant prostate cancer. Endocrine-Related Cancer 21 T67-T78. (doi:10.1530/ERC-14-0109)
11. Selth LA, Tilley WD & Butler LM 2012 Circulating microRNAs: macroutility as markers of prostate cancer? Endocrine-Related Cancer 19 R99-R113. (doi:10.1530/ERC-12-0010)
12. Skliris GP, Nugent ZJ, Rowan BG, Penner CR, Watson PH & Murphy LC 2010 A phosphorylation code for oestrogen receptor-α predicts clinical outcome to endocrine therapy in breast cancer. Endocrine-Related Cancer 17 589-597. (doi:10.1677/ERC-10-0030)
13. Tarulli G, Butler L, Tilley W & Hickey T 2014 Moving androgens up a notch in breast cancer. Endocrine-Related Cancer 21 T183-T202. (doi:10.1530/ERC-14-0248)
14. Ware KE, Garcia-Blanco MA, Armstrong AJ & Dehm SM 2014 Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer. Endocrine-Related Cancer 21 T87-T103. (doi:10.1677/ERC-13-0470)